Literature DB >> 4963518

The metabolic conversion of primidone (Mysoline) to phenobarbitone in patients under long-term treatment. An attempt to estimate the independent effect of primidone.

O V Olesen, M Dam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4963518     DOI: 10.1111/j.1600-0404.1967.tb05737.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  8 in total

Review 1.  Recent progress in epilepsy. Diagnostic procedures and treatment.

Authors:  B R Tharp
Journal:  Calif Med       Date:  1973-07

2.  Primidone intoxication in a child.

Authors:  M S Kappy; J Buckley
Journal:  Arch Dis Child       Date:  1969-04       Impact factor: 3.791

3.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

4.  Changes in primidone/phenobarbitone ratio during pregnancy and the puerperium.

Authors:  D Battino; S Binelli; L Bossi; M L Como; D Croci; C Cusi; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

Review 5.  Drug treatment of epilepsy: a review.

Authors:  D Rosenbloom; A R Upton
Journal:  Can Med Assoc J       Date:  1983-02-01       Impact factor: 8.262

6.  The effects of phenytoin on phenobarbitone and primidone metabolism.

Authors:  D G Lambie; R H Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

7.  Blood and cerebrospinal fluid pharmacokinetics of primidone and its primary pharmacologically active metabolites, phenobarbital and phenylethylmalonamide in the rat.

Authors:  S Nagaki; N Ratnaraj; P N Patsalos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jul-Sep       Impact factor: 2.569

8.  The history of barbiturates a century after their clinical introduction.

Authors:  Francisco López-Muñoz; Ronaldo Ucha-Udabe; Cecilio Alamo
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.